 | |
Displaying asco 2012 PowerPoint Presentations
Presentation Summary : ... monthly PSAs. Resume AD based on pre-specified criteria Hussain M et al. Proc ASCO 2012;Abstract 4. Study Design Overall Survival (OS): ...
Source : http://www.researchtopractice.com/sites/default/files/2012/Multitumor/RTPTV/RTPTV412/PPT/RTPTV412_Prostate.ppt
Case #4 Advanced Liver-Only Colorectal Cancer PPT
Presentation Summary : ... 15 q4w AGC refractory to prior FP confirmed by imaging Age 20-75, PS 0-2, No history of CPT-11 or Taxane Ueda ASCO 2012 Overall Survival Probability (%) ...
Source : http://www.gislides.com/slides/ASCO_GI_2013_files/Bendell%20GE%20Ca%20Discussant%20ASCO%20GI%202013.ppt
Presentation Summary : ... Abstract CRA3503. Primary endpoint: OS Secondary endpoints: PFS, ORR and safety Arnold D et al. Proc ASCO 2012;Abstract CRA3503. TML (ML18147) ...
Source : http://www.researchtopractice.com/sites/default/files/2012/Multitumor/RTPTV/RTPTV212/PPT/RTP-TV-12_Part2_CRC.ppt
Case #4 Advanced Liver-Only Colorectal Cancer PPT
Presentation Summary : ClinicalTrials.gov identifier: NCT00879333. 2 1 Van Cutsem GI ASCO 2012 Overall Survival (FAS) Van Cutsem GI ASCO 2012 Probability of overall survival (%) ...
Source : http://www.gislides.com/slides/ASCO_GI_2013_files/Bendell%20Targeted%20Therapies%20GE%20ca%20Oral%20ASCO%20GI%202013.ppt
Presentation Summary : ASCO’s eighth annual Clinical Cancer Advances report identifies this year’s most significant clinical cancer advances Highlights 17 most important advances, along ...
Source : http://www.cancerprogress.net/ppt/CCA_2012_Slide_Deck.ppt
Targeted Therapeutics in Urothelial Cancer: Early Results PPT
Presentation Summary : ... et al. GU ASCO 2012 Disparity in Reporting of Progression in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib According to Radiology and ...
Source : http://elcon.imedex.com/ELC/2012/6234/6234_Dreicer.ppt
Moving Carfilzomib into the Front-line Setting in Multiple ... PPT
Presentation Summary : 6/2/2012 7:57:44 PM Document presentation format: On-screen Show Other titles:
Source : http://static9.light-kr.com/documents/Orlowski%20-%20ASCO%202012%20-%20Disc%20of%20Carfilzomib%20Studies.ppt
Presentation Summary : Garon EB, et al. ASCO 2012. Abstract 7543. Summary EML4-ALK defines a new molecular subset of NSCLC Patients are more likely to be young, ...
Source : http://hematology.wustl.edu/conferences/presentations/Desai_2012-09-14.ppt
Presentation Summary : Combining semiconductor-based sequencing with amplicon-based cancer. gene panels: A . rapid next-gen approach to clinical cancer genotyping. Christopher L. Corless ...
Source : http://www.knightdxlabs.com/docs/default-document-library/asco-2012-poster.pptx?sfvrsn=2
ASCO 2011 slides - SARCOMA ONCOLOGY CENTER PPT
Presentation Summary : These findings have also been previously reported in earlier ASCO and CTOS meetings ... By June 2011 By Dec 2011 By Sept 2012 By June 2014 By June 2019 ...
Source : http://www.sarcomaoncology.com/pdf/SUCCEED%20ASCO%202011.ppt
Metastatic Renal Cell Carcinoma PPT
Presentation Summary : ... (43) Progressive Disease 13 (27) Withdrawn 1 (2) Dandamudi, CWG, ASCO 2010 ... Results soon GSK Pazopanib vs Sunitinib ASCO 2012 Aveo Tivozanib vs ...
Source : https://winshipcancer.emory.edu/media/file/Sea%20Island%202011/Sunday%202_%20Atkins.ppt
Diapositiva 1 - Home - AIOM - Associazione Italiana di ... PPT
Presentation Summary : ASCO Update: Italy Thomas J. Herzog, MD ... IRC Defined final OS analysis (end 2012) No IRC GOG 213 Primary endpoints: OS (secondary cytoreduction), OS ...
Source : http://www.aiom.it/C_Common/Download.asp?file=/doc/upload/Eventi_Congressi/VirtualMeeting/AIOM-ASCO-2010/14_Thomas_Herzog.ppt
Presentation Summary : Prostate Cancer Case Study Post ASCO 2010 64 year old Attorney, ... 12/2012 TrialTroveID-061973 Ixabepilone Ph3 To evaluate the study of ixabepilone (I), ...
Source : http://www.meccinc.com/UCDavisannAdvOnc101009-GUDQv2.ppt
Oncotype DX® June 2010 Post-Conference Clinical Data Review PPT
Presentation Summary : DX in clinical practice and other assays – ASCO posters. Genomic Health progress in other tumor types. Onco. typ. e DX Colon Cancer Assay. Renal cancer. Prostate ...
Source : http://genomichealth.envisioncomm.net/archives/24010/ppt/Oncotype_DXR_06_10_Post_Conference_Clinical_Data_Review.pptx
Therapeutic Decision Making in Advanced NSCLC: A 2012 Perspective PPT
Presentation Summary : A 2012 Perspective David R. Gandara, MD Professor of Clinical Medicine University of California Davis Cancer Center Davis, California ... Shaw AT, et al. ASCO 2011.
Source : http://s3.amazonaws.com/AdvancedNSCLC2012/CCO_Advanced_NSCLC_Decisions_2012_Slides.ppt
Presentation Summary : ASCO has an ad-hoc task force ... CT and PET to meet Medicare accreditation criteria by 2012 ASCO member of Access to Medical Imaging Coalition GAO Report ...
Source : http://clients.onlinevideoservice.com/goc/naeim.ppt
Presentation Summary : ... Abs LBA1, ASCO GU 2012 MDV 3100 Prolonged Survival by a Median of 4.8 Months in the Phase III Study AFFIRM Howard I. Scheret al, Abs LBA1, ...
Source : http://www.siuro.it/webfm_send/160
Subsequent line of targeted therapies for advanced RCC PPT
Presentation Summary : ... 28:1061-1068 ©2010 by American Society of Clinical Oncology Phase 3 trial of everolimus in patients with mRCC progressing on VEGFR-TKIs Cancer; ... (2012), doi ...
Source : http://hematology.wustl.edu/conferences/presentations/Mohamed_2012-03-02.ppt
